Research record

Rapamycin Rescues Age-Related Changes in Muscle-Derived Stem/Progenitor Cells from Progeroid Mice.

Preclinical research published by Molecular therapy. Methods & clinical development, indexed because it matched monitored longevity research terms. Inclusion in this index does not establish that an intervention is effective or safe.

Plain-language guide

Five questions to ask about this record

What this is
preclinical record from Molecular therapy. Methods & clinical development.
Why it may matter
It matched a longevity topic and may show how that evidence area is developing.
Evidence
Automated topic match 100%; this is not a medical rating.
Main limitation
One research record does not prove safety, effectiveness, or usefulness for an individual.
What changed
Source metadata was published or refreshed May 30, 2019.
Where to verify
Open the primary source below for methods, population, results, and limitations.
Published
May 30, 2019
Journal
Molecular therapy. Methods & clinical development
Authors
Yohei Kawakami, William S Hambright, Koji Takayama, Xiaodong Mu, Aiping Lu, James H Cummins, Tomoyuki Matsumoto, Takashi Yurube, Ryosuke Kuroda, Masahiro Kurosaka, Freddie H Fu, Paul D Robbins, Laura J Niedernhofer, Johnny Huard
DOI
10.1016/j.omtm.2019.05.011
Evidence class
preclinical
Record status
published
Match confidence
100%
Source feed
PubMed
Automated source synopsis

Preclinical research published by Molecular therapy. Methods & clinical development, indexed because it matched monitored longevity research terms. Inclusion in this index does not establish that an intervention is effective or safe.

Evidence snapshot

What the source actually supports

Evidence stage
Preclinical research
Study design
Journal Article
Evidence population
Preclinical (laboratory or animal research)
Participants
Not reported
Population
Not reported
Duration
Not reported
Intervention
Comparator
Not reported
Outcomes measured
Reported result
No reusable finding-level result is available in this record.

Main limitationPreclinical findings may not apply to people; the reusable source metadata does not provide enough detail to assess the result.

Safety and approvalThis index record does not establish safety, effectiveness, dose, or suitability for any person. A publication record is not a regulatory approval or treatment recommendation.

Source supportBibliographic citation metadata and controlled indexing terms only. Read the linked source for methods and results.

Evidence stage · preclinicalThis describes the study type, not whether an intervention is safe or effective.
Lab or animalHuman studyRandomized trialEvidence synthesis
Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Rapamycin · 100%Title contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.
  • Stem cells · 75%Title contains controlled topic terminology. Title supplies ageing or longevity context.

Automated source check 95% · update recency 50%. These figures help sort records; they are not medical ratings.

BibTeX · RIS

rapamycinstem cells
Read the original source →Export JSON